CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-26 | Kumar Ramesh Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +1,065,600 | 1,065,600 | ||
| 2018-02-23 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +73,220 | 73,220 | ||
| 2018-01-03 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +64,885 | 64,885 | ||
| 2017-04-26 | Kumar Ramesh President and CEO | Purchase | +23,810 | $2.10 | $50K | 102,227 |
| 2017-01-17 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +44,027 | 44,027 | ||
| 2016-12-15 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +12,673 | 12,673 | ||
| 2016-09-01 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +44,000 | 44,000 | ||
| 2016-07-29 | Kumar Ramesh President and CEO | Option exercise | +50,765 | $4.10 | $208K | 78,417 |
| 2016-07-29 | Kumar Ramesh President and CEO | Option exercise · Warrants (right to buy) | +38,071 | 38,071 | ||
| 2016-07-26 | Kumar Ramesh President and CEO | Option exercise · Subscription Right (right to buy) | −41,475 | 0 | ||
| 2016-01-26 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to buy) | +146,440 | 146,440 | ||
| 2015-09-25 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +87,500 | 87,500 | ||
| 2015-04-16 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2014-12-18 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +175,000 | 175,000 | ||
| 2014-02-10 | Kumar Ramesh President and CEO | Exercise or conversion | +20,000 | $6.00 | $120K | 296,500 |
| 2014-02-10 | Kumar Ramesh President and CEO | Sale | −20,000 | $15.11 | $302K | 276,500 |
| 2014-02-10 | Kumar Ramesh President and CEO | Exercise or conversion · Stock Option (right to buy) | −20,000 | 16,739 | ||
| 2014-02-07 | Kumar Ramesh President and CEO | Exercise or conversion | +13,543 | $6.00 | $81K | 290,043 |
| 2014-02-07 | Kumar Ramesh President and CEO | Exercise or conversion · Stock Option (right to buy) | −13,543 | 36,739 | ||
| 2014-02-03 | Kumar Ramesh President and CEO | Exercise or conversion | +20,000 | $6.00 | $120K | 296,500 |
Page 1 of 2 · 32 trades